I. Summary of the Core Content in Plain Language
Recently, Ant Group spent approximately 100 million yuan—just a fraction of its annual investment in its core businesses, which amount to several billion yuan—acquiring a low-profile company called Fengshi, which has only about 50 employees. This seemingly insignificant acquisition actually represents Ant Group using a small amount of money to purchase a valuable asset that others have struggled to obtain for over a decade: Fengshi holds the rights to settle commercial insurance claims with the special needs departments, international departments, and high-end private hospitals of 1,500 public hospitals. This acquisition is part of a larger initiative in China that has been discussed for over a decade but has yet to be fully implemented. The goal is to eliminate the need for patients to pay out of pocket for medical expenses, allowing commercial insurance companies to directly settle payments with hospitals. Companies like Tencent and Ping An are also entering the market to compete for this opportunity. With this acquisition, Ant Group has completed the final piece of its comprehensive health service ecosystem, which includes AI consultations, health management, doctor resources, and insurance sales. However, there are still several significant challenges that need to be overcome before this strategy can be successful.
---
II. Detailed Analysis by Dimension
1. Spending 100 Million Yuan to Acquire a Small Company is 10 Times More Cost-Effective than Building It from Scratch
Many people may wonder why Ant Group, a large company with substantial resources, would spend 100 million yuan to acquire a small team instead of building the necessary infrastructure on its own. The reason is straightforward: Over the past decade, all companies trying to implement direct commercial insurance settlements have encountered a major obstacle: hospitals strictly prohibit outsiders from accessing their core medical billing systems. Hospitals are concerned about potential disruptions to their insurance settlement processes and the security risks, and the changing reimbursement rules for commercial insurance make system maintenance extremely costly. As a result, companies had to develop separate systems to connect with each hospital individually. Leading players in this field either spent billions of yuan without gaining significant access to high-end hospitals or faced regulatory issues due to practices like linking drug sales with insurance sales. Fengshi has spent a decade building a network of connections with 1,500 high-end medical institutions, which Ant Group could not have achieved on its own in just a few years. Therefore, the 100 million yuan represents a very cost-effective investment.
2. Why is Direct Commercial Insurance Settlement Finally Possible Now?
Many people who have purchased commercial health insurance have experienced the inconvenience of having to pay out of pocket before receiving reimbursement. The direct settlement model aims to solve this problem: after receiving treatment, the insurance company will cover the eligible expenses directly from the hospital, leaving the patient with no additional out-of-pocket costs. Foreign companies have wanted to introduce this model in China for 20 years but failed to do so until now. The reasons for its sudden success are threefold:
- Hospitals’ Attitude Change: Hospitals, which previously relied mainly on medical insurance for revenue, are now eager to collaborate with commercial insurance companies to cover areas not covered by medical insurance, as the revenue from medical insurance has reached a ceiling.
- Policy Changes: The government has recently issued policies encouraging faster and more direct commercial insurance settlements, and a national unified settlement center has been established, removing previous barriers.
- Regulatory Clearing of Obstacles: Previously, insurance intermediaries manipulated the process by converting drug purchases into insurance purchases, but regulatory measures have eliminated this practice, allowing companies to focus on legitimate settlement services.
3. Ant Group’s Yearlong Preparation Leads to a Complete Health Service Ecosystem
The acquisition of Fengshi is the final piece in Ant Group’s strategic plan to create a comprehensive health service ecosystem. Ant Group already has an AI health assistant,薄荷 health for weight management and diet tracking, and a platform that connects users with qualified doctors. With Fengshi’s hospital settlement capabilities, the ecosystem covers the entire process from daily health management to medical treatment and reimbursement. However, there are still several challenges that need to be addressed:
- Doctor Resistance: Doctors may resist using insurance rules set by platforms, which can interfere with their treatment decisions.
- Trust Issues with Insurance Companies: Ant Group’s acquisition of Fengshi may raise concerns about data privacy, as other insurance companies may fear that their customer information will be used to optimize Ant Group’s products.
- Mismatch of Resources and Services: The health insurance products sold online by Ant Group are mainly affordable, while the high-end services offered by Fengshi’s network are not well-suited for online sales. There is no clear solution to this mismatch for now.
4. A Perfect Layout, but with Significant Challenges
Despite the seemingly perfect layout, there are several major hurdles that cannot be overcome with money alone:
- Doctor Resistance: Doctors may resist using insurance rules set by platforms.
- Trust Issues with Insurance Companies: There are concerns about data privacy and competition.
- Resource Mismatch: The online health insurance products do not align with the high-end services offered by Fengshi’s network.
Many in the industry are skeptical about the synergies Ant Group will achieve after this acquisition, as these issues cannot be resolved simply by investing money.